The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics

Duane L Sherrill, S. Guerra, A. Bobadilla, R. Barbee

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Several recent reports have presented evidence suggesting that adults with asthma have an accelerated rate of decline in pulmonary function compared with nonasthmatics. However, most of these studies have not taken into account the possible effect of comorbid lung disease in addition to asthma. This study was designed to determine if comorbid respiratory diseases modify or otherwise change the estimates of decline in forced expiratory volume in one second (FEV1). Study subjects were White, non-Mexican, American participants, who were ≥20 yrs of age at the initial survey and had at least one pulmonary function testing. Respiratory disease status, based on self-reported questionnaires and pulmonary function tests, were assessed during 12 surveys spanning a period of up to 20 yrs. There were 2,926 subjects who met the inclusion criteria, 214 (7.3%) had physician-confirmed asthma, 325 (11.1%) chronic obstructive pulmonary disease (COPD), and 125 (4.3%) both physician-confirmed asthma and COPD. Longitudinal analysis revealed that among those with longstanding asthma, FEV1 values were low but did not decline at a more rapid rate than normal. Likewise, subjects with both asthma and COPD had the lowest levels of FEV1, but also a rate of decline that was not significantly increased. Only those with COPD in the absence of asthma experienced both a low initial FEV1 level and a significantly steeper rate of decline. Based on these findings, the authors conclude that forced expiratory volume in one second does not decline more rapidly in asthmatics or in those with asthma and chronic obstructive pulmonary disease, compared with nonasthmatics.

Original languageEnglish (US)
Pages (from-to)95-100
Number of pages6
JournalEuropean Respiratory Journal
Volume21
Issue number1
DOIs
StatePublished - Jan 1 2003

Fingerprint

Asthma
Chronic Obstructive Pulmonary Disease
Forced Expiratory Volume
Physicians
Lung
Respiratory Function Tests
Lung Diseases
Surveys and Questionnaires

Keywords

  • Asthma
  • Chronic obstructive pulmonary disease
  • Forced expiratory volume in one second
  • Longitudinal

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics. / Sherrill, Duane L; Guerra, S.; Bobadilla, A.; Barbee, R.

In: European Respiratory Journal, Vol. 21, No. 1, 01.01.2003, p. 95-100.

Research output: Contribution to journalArticle

@article{b1354c969b8f4d7b89ba4b21391778b7,
title = "The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics",
abstract = "Several recent reports have presented evidence suggesting that adults with asthma have an accelerated rate of decline in pulmonary function compared with nonasthmatics. However, most of these studies have not taken into account the possible effect of comorbid lung disease in addition to asthma. This study was designed to determine if comorbid respiratory diseases modify or otherwise change the estimates of decline in forced expiratory volume in one second (FEV1). Study subjects were White, non-Mexican, American participants, who were ≥20 yrs of age at the initial survey and had at least one pulmonary function testing. Respiratory disease status, based on self-reported questionnaires and pulmonary function tests, were assessed during 12 surveys spanning a period of up to 20 yrs. There were 2,926 subjects who met the inclusion criteria, 214 (7.3{\%}) had physician-confirmed asthma, 325 (11.1{\%}) chronic obstructive pulmonary disease (COPD), and 125 (4.3{\%}) both physician-confirmed asthma and COPD. Longitudinal analysis revealed that among those with longstanding asthma, FEV1 values were low but did not decline at a more rapid rate than normal. Likewise, subjects with both asthma and COPD had the lowest levels of FEV1, but also a rate of decline that was not significantly increased. Only those with COPD in the absence of asthma experienced both a low initial FEV1 level and a significantly steeper rate of decline. Based on these findings, the authors conclude that forced expiratory volume in one second does not decline more rapidly in asthmatics or in those with asthma and chronic obstructive pulmonary disease, compared with nonasthmatics.",
keywords = "Asthma, Chronic obstructive pulmonary disease, Forced expiratory volume in one second, Longitudinal",
author = "Sherrill, {Duane L} and S. Guerra and A. Bobadilla and R. Barbee",
year = "2003",
month = "1",
day = "1",
doi = "10.1183/09031936.03.00017103",
language = "English (US)",
volume = "21",
pages = "95--100",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "1",

}

TY - JOUR

T1 - The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics

AU - Sherrill, Duane L

AU - Guerra, S.

AU - Bobadilla, A.

AU - Barbee, R.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Several recent reports have presented evidence suggesting that adults with asthma have an accelerated rate of decline in pulmonary function compared with nonasthmatics. However, most of these studies have not taken into account the possible effect of comorbid lung disease in addition to asthma. This study was designed to determine if comorbid respiratory diseases modify or otherwise change the estimates of decline in forced expiratory volume in one second (FEV1). Study subjects were White, non-Mexican, American participants, who were ≥20 yrs of age at the initial survey and had at least one pulmonary function testing. Respiratory disease status, based on self-reported questionnaires and pulmonary function tests, were assessed during 12 surveys spanning a period of up to 20 yrs. There were 2,926 subjects who met the inclusion criteria, 214 (7.3%) had physician-confirmed asthma, 325 (11.1%) chronic obstructive pulmonary disease (COPD), and 125 (4.3%) both physician-confirmed asthma and COPD. Longitudinal analysis revealed that among those with longstanding asthma, FEV1 values were low but did not decline at a more rapid rate than normal. Likewise, subjects with both asthma and COPD had the lowest levels of FEV1, but also a rate of decline that was not significantly increased. Only those with COPD in the absence of asthma experienced both a low initial FEV1 level and a significantly steeper rate of decline. Based on these findings, the authors conclude that forced expiratory volume in one second does not decline more rapidly in asthmatics or in those with asthma and chronic obstructive pulmonary disease, compared with nonasthmatics.

AB - Several recent reports have presented evidence suggesting that adults with asthma have an accelerated rate of decline in pulmonary function compared with nonasthmatics. However, most of these studies have not taken into account the possible effect of comorbid lung disease in addition to asthma. This study was designed to determine if comorbid respiratory diseases modify or otherwise change the estimates of decline in forced expiratory volume in one second (FEV1). Study subjects were White, non-Mexican, American participants, who were ≥20 yrs of age at the initial survey and had at least one pulmonary function testing. Respiratory disease status, based on self-reported questionnaires and pulmonary function tests, were assessed during 12 surveys spanning a period of up to 20 yrs. There were 2,926 subjects who met the inclusion criteria, 214 (7.3%) had physician-confirmed asthma, 325 (11.1%) chronic obstructive pulmonary disease (COPD), and 125 (4.3%) both physician-confirmed asthma and COPD. Longitudinal analysis revealed that among those with longstanding asthma, FEV1 values were low but did not decline at a more rapid rate than normal. Likewise, subjects with both asthma and COPD had the lowest levels of FEV1, but also a rate of decline that was not significantly increased. Only those with COPD in the absence of asthma experienced both a low initial FEV1 level and a significantly steeper rate of decline. Based on these findings, the authors conclude that forced expiratory volume in one second does not decline more rapidly in asthmatics or in those with asthma and chronic obstructive pulmonary disease, compared with nonasthmatics.

KW - Asthma

KW - Chronic obstructive pulmonary disease

KW - Forced expiratory volume in one second

KW - Longitudinal

UR - http://www.scopus.com/inward/record.url?scp=0037246603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037246603&partnerID=8YFLogxK

U2 - 10.1183/09031936.03.00017103

DO - 10.1183/09031936.03.00017103

M3 - Article

VL - 21

SP - 95

EP - 100

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 1

ER -